AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competition
July 25, 2023 at 10:41 AM EDT
Investors look for signs that Skyrizi, Rinvoq can take the baton as Humira sales falter
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|